Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.34 |
| ▸ | TTR | P02766 | 1/20 | 0.31 |
| ▸ | ALB | P02768 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12587111 | 0.84 | TTR (0.36) | TTRALB | |
| SCHEMBL2758513 | 0.83 | NPC1 (0.30) | — | |
| SCHEMBL10880463 | 0.82 | TTR (0.42) | FFAR4TTRALB | |
| SCHEMBL6667915 | 0.80 | TTR (0.41) | FFAR4TTRALB | |
| SCHEMBL12399933 | 0.75 | ALDH1A1 (0.38) | FFAR4TTRALB | |
| SCHEMBL26002403 | 0.72 | TTR (0.35) | FFAR4TTRALB | |
| SCHEMBL16960440 | 0.72 | TTR (0.35) | FFAR4TTRALB | |
| SCHEMBL10204233 | 0.72 | ALDH1A1 (0.39) | FFAR4TTRALB | |
| SCHEMBL12551765 | 0.72 | LOXL2 (0.31) | — | |
| SCHEMBL17639916 | 0.71 | TTR (0.43) | FFAR4TTRALB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230212177-A1 | COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT | KYULUX, INC. (JP) | 2023-07-06 | — | — | US | disclosed |
| US-20230137110-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-05-04 | — | — | US | disclosed |
| US-20180138421-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-05-17 | — | — | US | disclosed |
| US-20170349552-A1 | Treatment of Amyotrophic Lateral Sclerosis | NORTHWESTERN UNIVERSITY (US) | 2017-12-07 | — | — | US | disclosed |
| US-9809556-B2 | Treatment of amyotrophic lateral sclerosis | NORTHWESTERN UNIVERSITY (US) | 2017-11-07 | — | — | US | disclosed |
| US-20170244034-A1 | AROMATIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE INCLUDING THE SAME | NATIONAL TSING HUA UNIVERSITY (TW) | 2017-08-24 | — | — | US | disclosed |
| US-20160016911-A1 | Treatment of Amyotrophic Lateral Sclerosis | NORTHWESTERN UNIVERSITY | 2016-01-21 | — | — | US | disclosed |
| US-9145424-B2 | Treatment of amyotrophic lateral sclerosis | NORTHWESTERN UNIVERSITY (US) | 2015-09-29 | — | — | US | disclosed |
| US-20110237907-A1 | TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS | CAMBRIA PHARMACEUTICALS, INC. (US) | 2011-09-29 | — | — | US | disclosed |
| US-7807684-B2 | HIV reverse transcriptase inhibitors | MERCK SHARP & DOHME CORP. (US) | 2010-10-05 | — | — | US | disclosed |
| US-20080041438-A1 | Photoelectric conversion device | DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) | 2008-02-21 | — | — | US | disclosed |
| US-20070021442-A1 | HIV reverse transcriptase inhibitors | MERCK SHARP & DOHME CORP. | 2007-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160016911-A1 | Treatment of Amyotrophic Lateral Sclerosis | SMN1; SMN2, SOD1, NLN | FFAR4 3405/4885TTR 1506/4885ALB 3165/4885 |
| US-20230137110-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF | SLCO2B1, SLCO2A1, SLCO1B3 | FFAR4 4678/4885TTR 1483/4885ALB 2308/4885 |
| US-20170244034-A1 | AROMATIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE INCLUDING THE SAME | ARNT, AHR, CYP1A1 | FFAR4 2948/4885TTR 3019/4885ALB 952/4885 |
| US-20070021442-A1 | HIV reverse transcriptase inhibitors | POLRMT, RNGTT, POLR2E | FFAR4 4584/4885TTR 1482/4885ALB 4003/4885 |
| US-20180138421-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | CRY2, NR2E3, CRY1 | FFAR4 2848/4885TTR 2815/4885ALB 3044/4885 |
| US-20230212177-A1 | COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT | CRY1, CRY2, NR2E3 | FFAR4 4316/4885TTR 3715/4885ALB 4167/4885 |
| US-20170349552-A1 | Treatment of Amyotrophic Lateral Sclerosis | SMN1; SMN2, SOD1, NLN | FFAR4 3405/4885TTR 1506/4885ALB 3165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.